Business Context and Reporting Period
This Form 8-K, dated October 19, 2015, reports the consummation of the "Mergers" by LivaNova PLC. On this date, Sorin S.p.A. merged into LivaNova, and subsequently, Cyberonics, Inc. merged into a subsidiary of LivaNova, becoming a wholly-owned subsidiary. The transaction was treated as a "reverse acquisition" for accounting purposes, making Cyberonics the accounting acquirer. Consequently, LivaNova changed its fiscal year end from the last Friday in April to December 31.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, or margin figures for the reporting period. The only specific financial metric disclosed relates to debt restructuring:
- Debt Restructuring: LivaNova entered into an Amended and Restated Finance Contract with the European Investment Bank (EIB) on October 19, 2015. This agreement amends and restates an existing €100 million term loan finance contract originally dated May 6, 2014.
Material Changes
- Corporate Structure: Completion of the Sorin Merger and Cyberonics Merger, resulting in a new consolidated entity.
- Accounting Firm Change: KPMG LLP was dismissed as the independent registered public accounting firm. PricewaterhouseCoopers S.p.A. was engaged to audit financial statements for the period beginning April 25, 2015, through December 31, 2015.
- Fiscal Year Change: The company's fiscal year was changed to align with the calendar year (January 1 to December 31).
- Governance: Execution of Deeds of Indemnification for directors and officers.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, revenue outlook, or specific risk factors beyond the standard disclosures regarding the merger and accounting changes. Key operational notes include:
- Transition Reporting: LivaNova will file a Transition Report on Form 10-Q for the period April 25, 2015, to October 19, 2015, and a Transition Report on Form 10-K for the period April 25, 2015, to December 31, 2015.
- Accounting Treatment: Historical financial statements of Cyberonics will serve as the historical financial statements of the Company due to the reverse acquisition treatment.
Investor Verification Checklist
- Verify the terms of the Amended and Restated Finance Contract (Exhibit 10.2) regarding the €100 million EIB loan.
- Review the upcoming Transition Reports (Form 10-Q and Form 10-K) for the first consolidated financial results under the new fiscal year.
- Confirm the details of the reverse acquisition accounting treatment in the Transition Reports to understand the historical financial baseline.
- Examine the new Articles of Association (Exhibit 3.1) for changes in corporate governance.